Literature DB >> 33585562

miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions.

Na Li1,2, Rui Hou1,2, Tian Yang1,2, Caixia Liu1,2, Jun Wei1,2.   

Abstract

Objective: To clarify the role of microRNA-193a-3p (miR-193a-3p) in the pathogenesis of placenta accreta spectrum.
Methods: The placental tissue expression levels of miR-193a-3p and Ephrin-B2 (EFNB2) were compared between a placenta accreta spectrum group and a control group. Transwell migration and invasion assays were used to verify the effect of miR-193a-3p and EFNB2 on HTR-8/SVneo cells cultured in human endometrial stromal cell (hESC)-conditioned medium. Epithelial-mesenchymal transition (EMT)-related proteins were examined by western blotting to establish whether the EMT pathway was altered in placenta accreta spectrum. To determine whether EFNB2 is a target gene of miR-193a-3p, luciferase activity assays were performed.
Results: miR-193a-3p was upregulated but EFNB2 downregulated in the placenta accreta spectrum group and EFNB2 was a direct target of miR-193a-3p. Overexpression or inhibition of miR-193a-3p revealed that miR-193a-3p promoted the migration and invasion of HTR-8/SVneo cells cultured in hESC-conditioned medium. Furthermore, EMT was induced, as shown by increased N-cadherin, vimentin, MMP2, and MMP9 and decreased E-cadherin in the placenta accreta spectrum group and in HTR-8/SVneo cells transfected with miR-193a-3p mimics or si-EFNB2. The negative effect of miR-193a-3p inhibitor was reversed by co-transfection with si-EFNB2 in function studies and in analyses of EMT-related proteins in vitro.
Conclusion: miR-193a-3p which upregulated in placenta accreta spectrum group increases HTR-8/SVneo cell migration and invasion by targeting EFNB2 via the EMT pathway under decidua defect conditions to lead to placenta accreta spectrum.
Copyright © 2021 Li, Hou, Yang, Liu and Wei.

Entities:  

Keywords:  EFNB2; decidua defect; epithelial-mesenchymal transition; miR-193a-3p; placenta accreta spectrum

Year:  2021        PMID: 33585562      PMCID: PMC7873918          DOI: 10.3389/fmolb.2020.613802

Source DB:  PubMed          Journal:  Front Mol Biosci        ISSN: 2296-889X


  46 in total

1.  miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

Authors:  Hongwei Liang; Minghui Liu; Xin Yan; Yong Zhou; Wengong Wang; Xueliang Wang; Zheng Fu; Nan Wang; Suyang Zhang; Yanbo Wang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Jing Li; Xi Chen
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Ephrin-B2 mediates trophoblast-dependent maternal spiral artery remodeling in first trimester.

Authors:  Q Luo; X Liu; Y Zheng; Y Zhao; J Zhu; L Zou
Journal:  Placenta       Date:  2015-02-21       Impact factor: 3.481

3.  MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.

Authors:  Yue Pan; Jialei Hu; Jia Ma; Xia Qi; Huimin Zhou; Xiaoyan Miao; Wei Zheng; Li Jia
Journal:  Mol Carcinog       Date:  2018-05-02       Impact factor: 4.784

4.  Deregulated microRNA species in the plasma and placenta of patients with preeclampsia.

Authors:  Sheng Yang; Hailing Li; Qinyu Ge; Li Guo; Feng Chen
Journal:  Mol Med Rep       Date:  2015-03-04       Impact factor: 2.952

5.  Expression profiling of maternal plasma and placenta microRNAs in preeclamptic pregnancies by microarray technology.

Authors:  Tuba Gunel; Mohammad Kazem Hosseini; Ece Gumusoglu; Halil Ibrahim Kisakesen; Ali Benian; Kilic Aydinli
Journal:  Placenta       Date:  2017-02-22       Impact factor: 3.481

6.  The role of Delta-like 4 ligand/Notch-ephrin-B2 cascade in the pathogenesis of preeclampsia by regulating functions of endothelial progenitor cell.

Authors:  Xiaoxia Liu; Qingqing Luo; Yanfang Zheng; Xiaoping Liu; Ying Hu; Fang Wang; Li Zou
Journal:  Placenta       Date:  2015-07-14       Impact factor: 3.481

7.  Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.

Authors:  B Gellersen; R Kempf; R Telgmann; G E DiMattia
Journal:  Mol Endocrinol       Date:  1994-03

8.  Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.

Authors:  Zeljana Magic; Josefine Sandström; Gizeh Perez-Tenorio
Journal:  Int J Oncol       Date:  2019-10-04       Impact factor: 5.650

9.  Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.

Authors:  Haruo Nakano; Yoji Yamada; Tatsuya Miyazawa; Tetsuo Yoshida
Journal:  Int J Oncol       Date:  2013-04-15       Impact factor: 5.650

10.  MicroRNA expression profiling in placenta and maternal plasma in early pregnancy loss.

Authors:  Mohammad Kazem Hosseini; Tuba Gunel; Ece Gumusoglu; Ali Benian; Kilic Aydinli
Journal:  Mol Med Rep       Date:  2018-01-31       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.